5 Things You'll Want to Watch With AbbVie's Q3 Results
If 2017 ended right now, it would go down as AbbVie's (NYSE: ABBV) best ever. The biotech stock's price has risen a little more than the 50% gains AbbVie made during its first year as a stand-alone company in 2013. AbbVie has enjoyed good news for its current products and its pipeline.
But the year isn't over yet. AbbVie will provide an update on its third-quarter performance on Friday. Will those results allow the company to keep the momentum rolling? Here are five things to watch with AbbVie's third-quarter results.
Image source: Getty Images.
Source: Fool.com
Johnson & Johnson Stock
€134.00
-0.180%
With 33 Buy predictions and 1 Sell predictions Johnson & Johnson is one of the favorites of our community.
As a result the target price of 195 € shows a positive potential of 45.52% compared to the current price of 134.0 € for Johnson & Johnson.
